[(18)F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma

PURPOSE: In this prospective exploratory study, we evaluated the feasibility of [(18)F]fluorodeoxyglucose ([(18)F]FDG) PET/MRI-based chemotherapy response prediction in pancreatic ductal adenocarcinoma at two weeks upon therapy onset. MATERIAL AND METHODS: In a mixed cohort, seventeen patients treat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:EJNMMI Res
Päätekijät: Harder, Felix N., Jungmann, Friederike, Kaissis, Georgios A., Lohöfer, Fabian K., Ziegelmayer, Sebastian, Havel, Daniel, Quante, Michael, Reichert, Maximillian, Schmid, Roland M., Demir, Ihsan Ekin, Friess, Helmut, Wildgruber, Moritz, Siveke, Jens, Muckenhuber, Alexander, Steiger, Katja, Weichert, Wilko, Rauscher, Isabel, Eiber, Matthias, Makowski, Marcus R., Braren, Rickmer F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2021
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8319249/
https://ncbi.nlm.nih.gov/pubmed/34322781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-021-00808-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia